There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Healthequity (HQY) with bullish sentiments.
Medtronic (MDT)
TD Cowen analyst Josh Jennings reiterated a Buy rating on Medtronic today and set a price target of $110.00. The company’s shares closed last Thursday at $89.97.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of 7.4% and a 49.7% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Baxter International.
Currently, the analyst consensus on Medtronic is a Moderate Buy with an average price target of $96.88, which is a 5.9% upside from current levels. In a report issued on August 18, TipRanks – Google also upgraded the stock to Buy with a $103.00 price target.
